Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
1526
PUT
DELISTED
Amedisys
AMED
| $3.97M | 0.01% |
+100,000
| New | +$3.12M |
|
1527
Coherus Oncology
CHRS
$212M
| $3.97M | 0.01% |
137,451
-143,548
| -51% | -$3.63M |
|
|
INOV
1528
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $3.97M | 0.01% |
142,221
+124,357
| +696% | +$3.34M |
|
1529
MiMedx Group
MDXG
$633M
| $3.96M | 0.01% |
341,413
-145,064
| -30% | -$1.49M |
|
1530
Unisys
UIS
$196M
| $3.94M | 0.01% |
197,335
-109,185
| -36% | -$2.35M |
|
|
TA
1531
DELISTED
TravelCenters of America LLC
TA
| $3.94M | 0.01% |
53,084
-37,975
| -42% | -$3.04M |
|
|
TEN
1532
Tsakos Energy Navigation Ltd
TEN
$1.27B
| $3.94M | 0.01% |
82,657
+36,096
| +78% | +$1.7M |
|
|
TROVW
1533
DELISTED
TrovaGene, Inc. Warrant
TROVW
| $3.94M | 0.01% |
525,750
-50
| -0% | -$320 |
|
|
QEP
1534
CALL
DELISTED
QEP RESOURCES, INC.
QEP
| $3.92M | 0.01% |
211,600
+52,000
| +33% | +$1.07M |
|
1535
Minerals Technologies
MTX
$2.24B
| $3.89M | 0.01% |
57,128
-57,925
| -50% | -$4.02M |
|
1536
Chegg
CHGG
$87.9M
| $3.89M | 0.01% |
496,292
+64,109
| +15% | +$507K |
|
|
COHR
1537
DELISTED
Coherent Inc
COHR
| $3.87M | 0.01% |
60,981
+12,971
| +27% | +$832K |
|
1538
TAL Education Group
TAL
$6.43B
| $3.85M | 0.01% |
655,110
+506,070
| +340% | +$3.06M |
|
1539
UFP Industries
UFPI
$4.89B
| $3.85M | 0.01% |
222,210
+79,617
| +56% | +$1.46M |
|
|
EGL
1540
DELISTED
Engility Holdings, Inc.
EGL
| $3.85M | 0.01% |
153,009
+93,056
| +155% | +$2.64M |
|
|
TTPH
1541
CALL
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $3.84M | 0.01% |
+4,050
| New | +$3.31M |
|
1542
Banco Bradesco
BBD
$35.4B
| $3.84M | 0.01% |
+891,740
| New | +$4.11M |
|
|
DSCI
1543
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $3.83M | 0.01% |
535,428
+271,043
| +103% | +$2.04M |
|
|
FBR
1544
DELISTED
Fibria Celulose Sa
FBR
| $3.83M | 0.01% |
281,043
+69,409
| +33% | +$971K |
|
|
CLR
1545
CALL
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $3.81M | 0.01% |
+90,000
| New | +$4.28M |
|
1546
Owens Corning
OC
$11.6B
| $3.81M | 0.01% |
92,277
+90,142
| +4,222% | +$3.69M |
|
|
TPCO
1547
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $3.8M | 0.01% |
244,602
+65,491
| +37% | +$1.11M |
|
1548
Marcus & Millichap
MMI
$1.23B
| $3.79M | 0.01% |
82,257
-20,824
| -20% | -$888K |
|
1549
Wingstop
WING
$3.1B
| $3.79M | 0.01% |
+133,449
| New | +$3.85M |
|
1550
Lamar Advertising Co
LAMR
$15.4B
| $3.78M | 0.01% |
+65,832
| New | +$3.92M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.